ArticleCurrent journal of neurology2021

Cladribine tablets are a cost-effective strategy in high-disease activity relapsing multiple sclerosis patients in Iran.

Nayyereh Ayati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.